Welcome to our dedicated page for Kewaunee Scienti news (Ticker: KEQU), a resource for investors and traders seeking the latest updates and insights on Kewaunee Scienti stock.
Kewaunee Scientific Corporation (NASDAQ: KEQU) is a manufacturing company specializing in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products. This news page aggregates company announcements, earnings releases, and other disclosures so readers can follow developments that affect KEQU stock and Kewaunee’s operations.
Recent news has focused on quarterly and annual financial results, where Kewaunee reports performance for its domestic, international, and corporate segments and discusses trends in sales, profitability, and order backlog. The company also provides updates on non-GAAP metrics such as EBITDA, Segment EBITDA, Adjusted EBITDA, and adjusted net earnings, including the impact of acquisition and integration costs related to NuAire.
Investors and observers can also find coverage of capital structure and financing actions, including debt refinancing, early repayment of seller notes associated with the NuAire acquisition, and amendments to loan agreements. In addition, Kewaunee issues news about share repurchase program amendments and its approach to capital allocation.
Corporate governance and strategic matters appear in items such as board appointments, proxy-related communications, and disclosures about strategic investments in people, processes, and technology at the corporate level. Operational and commercial updates include participation in industry events like the Arablab Live trade show and information about Kewaunee’s global footprint, including its manufacturing facilities in Statesville, North Carolina and Bangalore, India and its sales offices in multiple countries.
By reviewing the KEQU news feed on this page, readers can track how Kewaunee communicates about its financial performance, acquisitions, international activities, and corporate initiatives over time.
Kewaunee Scientific (NASDAQ: KEQU), a global leader in laboratory, healthcare, and technical furniture products, announces its participation in the 2024 Arablab Live tradeshow in Dubai from September 24-26. The event will host industry professionals from over 120 countries, showcasing innovations in life sciences, clean energy, industrial, and chemical sectors.
Kewaunee's executive and sales teams will be present at Hall 3, Stand 708 of the Dubai World Trade Centre, offering product demonstrations and networking opportunities. The company aims to connect with international partners, exchange knowledge, and highlight its innovative solutions for laboratory spaces worldwide.
Kewaunee Scientific (NASDAQ: KEQU) has announced plans to release its first quarter fiscal year 2025 financial results on Wednesday, September 11, 2024, after the close of trading. The information will be available on the company's website following the release.
Kewaunee Scientific, founded in 1906, is a global leader in designing, manufacturing, and installing laboratory, healthcare, and technical furniture products. The company's product range includes steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.
Headquartered in Statesville, North Carolina, Kewaunee Scientific has sales offices in the United States, India, Saudi Arabia, and Singapore. It operates three manufacturing facilities in Statesville and one in Bangalore, India, serving domestic and international markets.
Kewaunee Scientific announced its fiscal year and fourth quarter results for the period ending April 30, 2024. Fourth quarter sales increased by 5% to $56.7 million, with adjusted net earnings rising to $4.6 million from $1 million year-over-year. Adjusted diluted earnings per share for the quarter were $1.55, up from $0.34. For the fiscal year, sales dropped by 7.2% to $203.8 million, while adjusted net earnings surged to $12.3 million from $738,000. Adjusted EBITDA for the fiscal year was $20.7 million, up from $7.5 million. The order backlog rose to $155.6 million. The company also noted two significant non-recurring transactions: the annuitization of its pension obligations and the reversal of a valuation allowance, impacting earnings and EBITDA.
Kewaunee Scientific (NASDAQ: KEQU) announced plans to release financial results for its fourth quarter and fiscal year ended April 30, 2024, on June 26, 2024, after market close. These results will be accessible on the company's website. Founded in 1906, Kewaunee is a global leader in designing, manufacturing, and installing laboratory, healthcare, and technical furniture products. The company operates three manufacturing facilities in Statesville, North Carolina, and one in Bangalore, India, serving both domestic and international markets. Sales offices are located in the U.S., India, Saudi Arabia, and Singapore.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.